Closed
Call for capabilities: Establishment of a good manufacturing practice human amniotic fluid cell seed bank
Collaborative cell banking initiative
Last Update: June 27, 2026
Funding available
$ 250,000
Timeline
- Open Date : November 15, 2023
- Closing date : January 22, 2024
Location
Canada
Overview
Le programme Défi du CNRC « Technologies de rupture au service des thérapies cellulaires et géniques » soutient un projet de collaboration au Canada pour établir une banque de cellules du liquide amniotique humain conforme aux bonnes pratiques de fabrication. Il vise la collecte, l’expansion, l’entreposage, la reprogrammation en CSPI et les essais de sécurité associés.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Develop strategic partnerships
- Develop a new product or service
- Conduct research and development activities
Eligible Funding
- Maximum amount : 250,000 $
- Up to 100% of project cost
Timeline
- Open Date : November 15, 2023
- Closing date : January 22, 2024
Eligible candidates
Eligible Industries
- All industries
Location
- Canada
Legal structures
- All legal structures
Annual revenue
- All revenue ranges
Organisation size
- 500 employees maximum
Audience
- All groups
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Collecting, expanding, storing, and managing human amniotic fluid cell seed stocks
- Reprogramming at least one male and one female hAFC seed stock into induced pluripotent stem cells (iPSC)
- Providing access to hAFC seed stock vials for future product development upon formal request and written consent from the NRC
Official resources
Eligibility
Who is eligible?
- Canadian small and medium-sized enterprises (those with fewer than 500 employees)
- Not-for-profit research organizations
- Research institutions
- Academic institutions
Eligible expenses
- Salaries for highly qualified personnel working on the project activities
- Research support costs, including consumable materials, supplies, equipment rentals, and facility rentals
- Costs for on-duty travel required to execute the project and limited conference travel for highly qualified personnel
- Amounts invoiced by a contractor for services rendered relating directly to the project
- Indirect costs up to a maximum of 10% of total eligible costs
Ineligible Costs and Activities
- Purchase of land
- Leasehold interest
- Property taxes
- Any portion of costs subject to refunds, rebates or credits, including HST, GST and PST
- Costs paid by the NRC
Selection criteria
- Proposals are assessed using the technical requirements and the criteria provided in Annex A.
- The NRC seeks projects that fit the objectives of the collaborative call and are feasible in terms of implementing NRC technologies and expertise.
- Projects are evaluated on team composition, NRC collaboration, alignment, quality, eligibility, and funding.
How to apply
- Register for this call and the Q&A session by sending an email to NRC.HealthProgram-ProgrammeSante.CNRC@nrc-cnrc.gc.ca.
Processing and Agreement
- After receiving the notice of project approval, applicants must enter into a collaborative research agreement with all project collaborators or a funding agreement with the NRC.
- If an agreement cannot be finalized within a reasonable timeframe, funding may be cancelled.
Additional information
- This call for proposals is closed.
- Register for the call and the Q&A session by sending an email to NRC.HealthProgram-ProgrammeSante.CNRC@nrc-cnrc.gc.ca.
- Q&A with the NRC research team requires registration.
Contacts
Frequently Asked Questions about the Call for capabilities: Establishment of a good manufacturing practice human amniotic fluid cell seed bank Program
What is the Call for capabilities: Establishment of a good manufacturing practice human amniotic fluid cell seed bank?
Le programme Défi du CNRC « Technologies de rupture au service des thérapies cellulaires et géniques » soutient un projet de collaboration au Canada pour établir une banque de cellules du liquide amniotique humain conforme aux bonnes pratiques de fabrication. Il vise la collecte, l’expansion, l’entreposage, la reprogrammation en CSPI et les essais de sécurité associés.
How much funding can be received?
Call for capabilities: Establishment of a good manufacturing practice human amniotic fluid cell seed bank Funds up to 100% of admissible expenses, capped at $250,000 per project.
What is the deadline to apply?
The application deadline for this grant program was January 22, 2024.
Who is eligible for the Call for capabilities: Establishment of a good manufacturing practice human amniotic fluid cell seed bank program?
To be eligible for the Call for capabilities: Establishment of a good manufacturing practice human amniotic fluid cell seed bank program, you must:
Teams must be willing to collaborate with researchers from the NRC's Human Health Therapeutics Research Centre.
Teams must provide a minimum of 1:1 matching funds (cash or in-kind) contribution.
The project team must demonstrate commitment to EDI and GBA+.
What expenses are eligible under Call for capabilities: Establishment of a good manufacturing practice human amniotic fluid cell seed bank?
Collecting, expanding, storing, and managing human amniotic fluid cell seed stocks
Reprogramming at least one male and one female hAFC seed stock into induced pluripotent stem cells (iPSC)
Providing access to hAFC seed stock vials for future product development upon formal request and written consent from the NRC
Who can I contact for more information about the Call for capabilities: Establishment of a good manufacturing practice human amniotic fluid cell seed bank?
You can contact National Research Council Canada (NRC) by email at NRC.HealthProgram-ProgrammeSante.CNRC@nrc-cnrc.gc.ca or by phone at none.
Where is the Call for capabilities: Establishment of a good manufacturing practice human amniotic fluid cell seed bank available?
The Call for capabilities: Establishment of a good manufacturing practice human amniotic fluid cell seed bank program is available across Canada.